Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. 1993

Y Allemann, and F F Horber, and M Colombo, and P Ferrari, and S Shaw, and P Jaeger, and P Weidmann
Medizinische Universitätspoliklinik, University of Berne, Switzerland.

Lean, healthy normotensive sons of essential hypertensive parents (OHyp) have lower insulin sensitivity (SI) than sons of normotensive parents (ONorm). We have tried to find out whether this disturbance in insulin metabolism is related to altered body fat distribution, fuel metabolism, or both. 21 OHyp and 21 ONorm of similar age and body-mass index were investigated after fasting overnight. Body composition was assessed by dual-energy X-ray absorptiometry and fuel metabolism by indirect calorimetry and urinary nitrogen excretion. Plasma insulin and glucose concentrations were measured during the frequent sampling intravenous glucose tolerance test, and SI was calculated by the minimum model method. Systolic blood pressure and heart rate were slightly but not significantly higher in OHyp than ONorm but the groups did not differ in fasting plasma insulin or glucose concentrations, carbohydrate or lipid oxidation, lean and fat mass, bone mineral content, or distribution of body fat. By contrast, SI was significantly lower in OHyp than ONorm (8.2 [0.7] vs 13.4 [1.5] 10(-4) L mU-1 min-1, p < 0.01). Within the whole study population upper-body fat mass was positively correlated with fasting plasma insulin (r = 0.33, p < 0.03) and lipid oxidation was positively correlated with SI (r = 0.35, p < 0.04) and negatively correlated with subscapular/triceps skinfold thickness (r = -0.43, p < 0.01). Thus, impairment of SI precedes both the development of overt hypertension and gain or redistribution of body fat. Therefore, the concept that SI is low as a result of altered fat distribution has to be reconsidered, at least in young male offspring of hypertensive parents.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001823 Body Composition The relative amounts of various components in the body, such as percentage of body fat. Body Compositions,Composition, Body,Compositions, Body
D002153 Calorimetry, Indirect Calculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange. Calorimetry, Respiration,Calorimetries, Indirect,Calorimetries, Respiration,Indirect Calorimetries,Indirect Calorimetry,Respiration Calorimetries,Respiration Calorimetry
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Allemann, and F F Horber, and M Colombo, and P Ferrari, and S Shaw, and P Jaeger, and P Weidmann
March 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
Y Allemann, and F F Horber, and M Colombo, and P Ferrari, and S Shaw, and P Jaeger, and P Weidmann
November 1998, American journal of hypertension,
Y Allemann, and F F Horber, and M Colombo, and P Ferrari, and S Shaw, and P Jaeger, and P Weidmann
April 1992, Hypertension (Dallas, Tex. : 1979),
Y Allemann, and F F Horber, and M Colombo, and P Ferrari, and S Shaw, and P Jaeger, and P Weidmann
August 2001, Metabolism: clinical and experimental,
Y Allemann, and F F Horber, and M Colombo, and P Ferrari, and S Shaw, and P Jaeger, and P Weidmann
January 1994, Hypertension (Dallas, Tex. : 1979),
Y Allemann, and F F Horber, and M Colombo, and P Ferrari, and S Shaw, and P Jaeger, and P Weidmann
October 2008, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Y Allemann, and F F Horber, and M Colombo, and P Ferrari, and S Shaw, and P Jaeger, and P Weidmann
April 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Y Allemann, and F F Horber, and M Colombo, and P Ferrari, and S Shaw, and P Jaeger, and P Weidmann
April 1998, Journal of cardiovascular pharmacology,
Y Allemann, and F F Horber, and M Colombo, and P Ferrari, and S Shaw, and P Jaeger, and P Weidmann
January 1988, Journal of cardiovascular pharmacology,
Y Allemann, and F F Horber, and M Colombo, and P Ferrari, and S Shaw, and P Jaeger, and P Weidmann
July 1993, BMJ (Clinical research ed.),
Copied contents to your clipboard!